Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
|Articles|December 1, 2005
- Volume 0 0
Prescription Containers
Advertisement
EPS Inc (Ivyland, Pa) recently introduced additions to its line of prescription containers. The containers now are available in plastic and glass vials and bottles with either child-resistant or regular screw caps. The bottles are graduated for quick visual identification and are available in 2-to 16-oz sizes. The vials are available from 6 to 60 dram. The plastic ointment jars are available in 1/2-oz to 16-oz jars. For more information, visit www.medi-dose.com, or call 800-523-8966.
Articles in this issue
almost 21 years ago
CAN YOU READ THESE Rxs?almost 21 years ago
Bar Coding Thwarts Illegitimate Drug Usealmost 21 years ago
COMPREHENSIVE CARE CLINIC: DIABETES: Diabetes-related Stress and Depressionalmost 21 years ago
Hypertension Counseling Requires a Multifactorial Approachalmost 21 years ago
COMPOUNDING HOTLINEalmost 21 years ago
Pharmacy Law: Duty to Warn Waived When Patient Refuses Counselingalmost 21 years ago
EnterpriseRx Pharmacy Management Systemalmost 21 years ago
Hospital Installs Automated Medication Cabinetsalmost 21 years ago
"Smartphones" Help with Clinical Trial Informationalmost 21 years ago
HIT Needs Medicare's LeadershipAdvertisement
Related to this article
Investigational anti-amyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease
2
Ramantamig's 93.6% ORR and Outpatient CRS Control
3
CagriSema Tops Tirzepatide 5 mg for Weight Loss in REIMAGINE 5
4
Influenza Vaccines Continue to Reduce Severe Disease and Death Across High-Risk Groups, Evidence Review Finds
5